Manel Juan

51PUBLICATIONS
334CO-AUTHORS
Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Apr 24, 2026
IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.

|Mar 30, 2026
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer.

Natalia Díaz-Valdivia, Paula Duch, Rafael Ikemori

|Mar 03, 2026
Enhanced antitumoral activity of the academic CAR-T ARI0002h against normal and low BCMA-expressing myeloma cells after incorporating a transmembrane CD28 domain.

Oriol Cardus, Joan Mañé Pujol, Anna de Daniel

|Feb 16, 2026
Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO).

Tomás Pascual, Maria Vidal, Juan M Cejalvo

|Dec 17, 2025
Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition.

Ganesh Ramesh, Zsolt Sebestyen, Anil Kumar Deshantri

|Dec 11, 2025
Specific Instability of HLA-A*03:01 Expression in HEK-293 Cells.

María Area-Navarro, Alba Pastor-Moreno, Erika Scholz

Pageof 9

Frequent Collaborators

10 joint publications

Valentín Ortiz-Maldonado

9 joint publications

Carlos Fernández de Larrea

8 joint publications

Julio Delgado

8 joint publications

Beatriz Martín-Antonio